|Bid||0.00 x 800|
|Ask||0.00 x 1400|
|Day's Range||13.99 - 15.58|
|52 Week Range||11.70 - 48.75|
|Beta (5Y Monthly)||2.80|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Shareholders in Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ) may be thrilled to learn that the analysts have...
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of 55.43% and 714.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?